EIF4E and neoplasm: eIF4E is a particularly attractive oncogenic target as it forms part of the eIF4F complex, which performs a critical role in mediating cap-dependent protein synthesis2 and whose components (eIF4E, eIF4A and eIF4G) are frequently mis-regulated in many tumours and often associated with poor prognosis in patients and chemoresistance3–5.